Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Collaboration revenue	$ 285
Operating expenses:
Research and development	29,694	$ 12,522
General and administrative	14,206	9,687
Total operating expenses	43,900	22,209
Loss from operations	(43,615)	(22,209)
Other income:
Interest income	102	82
Total other income	102	82
Net loss	(43,513)	(22,127)
Comprehensive loss	$ (43,513)	$ (22,127)
Net loss per share attributable to common stockholders—basic and diluted	$ (3.35)	$ (2.59)
Weighted-average common shares outstanding—basic and diluted	12,986,101	8,590,205